Avraham Shterling

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

Neovasc Medical Ltd. develops medical devices for the treatment of refractory angina. It offers minimally invasive treatment for Ischemic heart disease. The company was founded in 2002 by Boaz Lifschitz and is headquartered in Or Yehuda, Israel

ValCare Medical, Inc. engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases. The firm develops a unique transcatheter device, which will provide the capability to implant the mitral annuloplasty device interventionally without surgery. The company was founded by Samuel M. Shaolian in 2012 and is headquartered in Herzlyia Pituach, Israel.

A.M. Accelmed Management (2009) Ltd (Accelmed) is a private equity subsidiary of Arkin Moshe founded in 2009. The firm is headquartered in Miami, Florida.

Peregrine Ventures Management Ltd (Peregrine Ventures) is a venture capital firm founded in 1999 by Eyal Lifschitz and Boaz Lifschitz. The firm is headquartered in Or Yehuda, Israel.

Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021.

Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Momentis Surgical Ltd. provides robot-assisted surgeries. It offers Hominis, a surgical system with surgical and ergonomics capabilities. The company was founded by Vitaly Vishnepolsky and Nir Shvalb and is headquartered in Or Yehuda, Israel.

Keystone Dental, Inc. engages in the provision of oral healthcare company. It delivers advanced, easy-to-use implants, biomaterials and planning software for dental professionals. The company was founded on March 2006 and is headquartered in Burlington, MA.

Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA.

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. The company is headquartered in New York, NY.

Part of Kyocera Corp., Electro-Chemical Research Ltd. is an Israeli company specializing in electronics research and development. The company holds patents for high-capacity storage devices and batteries. The company was founded by Niles A. Fleischer, Eyal Lifschitz.

Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom.

Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel.

NeuroSonix Ltd. develops and markets non-invasive ultrasound-based embolic protection technology and devices. Its products include EmBlocker, an ultrasonic device, which is used to deflect gaseous and solid emboli during open heart surgeries. The company was founded by Simcha Milo and Nathan Sela in 2002 and is headquartered in Rehovot, Israel.

MedMinder Systems, Inc. provides services that simplify medication management and improve medication adherence. It operates as service agency that empowers seniors, the chronically ill and people with disabilities to maintain their independence and avoid long term care facilities and (re-)hospitalization. The firm also provides medication adherence, telehealth, medication compliance, medication management, automated pill dispensers and healthcare services. The company was founded by Woodie Flowers, Andrew S. Dibner and Eran Shavelsky in 2007 and is headquartered in Needham, MA.

Cordio Medical Ltd. engages in the provision of solutions for monitoring health conditions through speech analysis. The company was founded by Sigal Kremer Tal, Ze'ev Schlik, Shelly Lotan, and Aviv Lotan in 2013 and is headquartered in Or Yehuda, Israel.

Part of Meridian Bioscience, Inc., Exalenz Bioscience, Inc. is a leading provider of life science raw materials and diagnostic solutions. The company is located in the US and was founded by Uri Geiger. The American company specializes in advanced molecular and immunological reagents that offer accurate and reliable results for disease diagnosis and monitoring. The company's diagnostic platforms and tests are flexible to meet any diagnostic testing needs.

ETV Energy Ltd. develops lithium ion batteries for electric vehicles, hybrids and high-end markets. Its battery technology is based on high voltage nickel-manganese-oxide (spinel) cathode material. The firm also develops and markets advanced battery technology that addresses the global automotive industry's tightening embrace of electric vehicles, hybrid vehicles and extended-range electric vehicles (EREVs). The company was founded in 2008 by Dror Ben David, Arieh Meitav, Alexander Zinigrad, Doron Aurbach and Shalom Luski and is headquartered in Ramat-Gan, Israel.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services.

UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only.

Part of Medtronic Plc, Medtronic Instent, Inc. is a company that designs, develops, manufactures and markets stents. The company is based in Eden Prairie, MN.